Fundraising Fox

Rakuten Med

San Diego, US · Founded 2010 · 1 known investors

rakuten-med.com ↗

Rakuten Medical is a biotechnology company developing cancer treatments based on its Alluminox platform, an investigational technology built on photoimmunotherapy that combines a drug, device, and related components. It aims to create and commercialize drugs and devices to treat cancers.

BiotechHealthtechMedical Devicesin /rakuten-medical

Founders & leadership

HM
Hiroshi MikitaniExecutive Officer, Director
AB
Abhijit BhatiaExecutive Officer
TP
Tiffany PiecewiczExecutive Officer
SS
Suzane SanExecutive Officer
MG
Miguel Garcia-GuzmanDirector
MM
Minami MaedaExecutive Officer
TS
Toshiaki SuzukiExecutive Officer
SS
Scott SalkaExecutive Officer, Director
DC
David ChaoDirector
MD
Mazen DarwazahDirector
HM
Hiroshi MoriDirector
EK
Eiichi KagaDirector

Investors · 1

Taiwania CapitalTaipei · $3M – $85M

Reported raises · per SEC filings

Form D private placements
▶$111.5MraisedApr 2026 · 26 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Hiroshi MoriDirector
  • Hiroyuki KodamaExecutive Officer
  • Hiroshi MikitaniExecutive Officer, Director
  • Suzane SanExecutive Officer
  • David ChaoDirector
  • Toshiaki SuzukiExecutive Officer
  • Carlos GarciaExecutive Officer
  • Maeda MinamiExecutive Officer
  • Abhijit BhatiaExecutive Officer
  • Kentaro HyakunoDirector
  • Nitin NohriaDirector
  • Mazen DarwazahDirector
  • Eiichi KagaDirector
  • Miguel Garcia-GuzmanDirector
  • Tiffany PiecewiczExecutive Officer
Offering amount
$116.7M
Amount sold
$111.5M
First sale
Jul 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.9MraisedMay 2025 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Abhijit BhatiaExecutive Officer
  • Nitin NohriaDirector
  • David ChaoDirector
  • Tiffany PiecewiczExecutive Officer
  • Mazen DarwazahDirector
  • Suzane SanExecutive Officer
  • Hiroshi MikitaniExecutive Officer, Director
  • Hiroshi MoriDirector
  • Miguel Garcia-GuzmanDirector
  • Eiichi KagaDirector
  • Minami MaedaExecutive Officer
  • Toshiaki SuzukiExecutive Officer
  • Carlos GarciaExecutive Officer
  • Kentaro HyakunoDirector
Offering amount
$1.9M
Amount sold
$1.9M
First sale
Dec 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.2MraisedMar 2024 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David ChaoDirector
  • Carlos GarciaExecutive Officer
  • Mazen DarwazahDirector
  • Suzane SanExecutive Officer
  • Hiroshi MoriDirector
  • Hiroshi MikitaniExecutive Officer, Director
  • Kentaro HyakunoDirector
  • Hiroshi TakasawaDirector
  • Nitin NohriaDirector
  • Miguel Garcia-GuzmanDirector
  • Takashi ToraishiExecutive Officer, Director
  • Abhijit BhatiaExecutive Officer
  • Agatha MartindaleExecutive Officer
  • Minami MaedaExecutive Officer
  • Tiffany PiecewiczExecutive Officer
  • Toshiaki SuzukiExecutive Officer
Offering amount
$4.2M
Amount sold
$4.2M
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.2MraisedOct 2023 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kentaro HyakunoDirector
  • Mazen DarwazehDirector
  • Hiroshi MoriDirector
  • Nitin NohriaDirector
  • David ChaoDirector
  • Toshiaki SuzukiExecutive Officer
  • Takashi ToraishiExecutive Officer, Director
  • Abhijit BhatiaExecutive Officer
  • Tiffany PiecewiczExecutive Officer
  • Hiroshi TakasawaDirector
  • Hiroshi MikitaniExecutive Officer, Director
  • Miguel Garcia-GuzmanDirector
  • Carlos GarciaExecutive Officer
Offering amount
$2.2M
Amount sold
$2.2M
First sale
Jun 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$104.8MraisedSep 2023 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Tiffany PiecewiczExecutive Officer
  • Miguel Garcia-GuzmanDirector
  • Nitin NohriaDirector
  • David ChaoDirector
  • Carlos GarciaExecutive Officer
  • Mazen DarwazehDirector
  • Takashi ToraishiExecutive Officer, Director
  • Kentaro HyakunoDirector
  • Hiroshi MikitaniExecutive Officer, Director
  • Abhijit BhatiaExecutive Officer
  • Hiroshi MoriDirector
  • Hiroshi TakasawaDirector
Offering amount
$123.7M
Amount sold
$104.8M
First sale
Aug 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$70MraisedDec 2022 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Miguel Garcia-GuzmanDirector
  • Carlos GarciaExecutive Officer
  • Tiffany PiecewiczExecutive Officer
  • Hiroshi MoriDirector
  • David ChaoDirector
  • Kentaro HyakunoDirector
  • Abhijit BhatiaExecutive Officer
  • Takashi ToraishiExecutive Officer, Director
  • Nitin NohriaDirector
  • Hiroshi MikitaniExecutive Officer, Director
  • Hiroshi TakasawaDirector
Offering amount
$90M
Amount sold
$70M
First sale
Dec 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$166MraisedJul 2021 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Miguel Garcia-GuzmanExecutive Officer, Director
  • David ChaoDirector
  • Takashi ToraishiExecutive Officer, Director
  • Kentaro HyakunoDirector
  • Ann McGuireExecutive Officer
  • Hiroshi MoriDirector
  • Carlos GarciaExecutive Officer
  • Hiroshi TakasawaDirector
  • Nitin NohriaDirector
  • Hiroshi MikitaniExecutive Officer, Director
Offering amount
$291M
Amount sold
$166M
Sales commissions
$3M
Placement agents
TAP Securities LLC, Momentum Capital Markets, LLC
First sale
Jul 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedJan 2021 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Miguel Garcia-GuzmanExecutive Officer, Director
  • Takashi ToraishiExecutive Officer, Director
  • Hiroshi MikitaniExecutive Officer, Director
  • Brenton KeathExecutive Officer
  • Carlos GarciaExecutive Officer
  • David ChaoDirector
  • Kentaro HyakunoDirector
  • Hiroshi MoriDirector
Offering amount
$15M
Amount sold
$15M
First sale
Dec 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.